Skip to content
Screener

Bio-Techne TECH US — Revenue

Other geography segments

CN
$24.48M
GB
$12.85M

Similar metrics at other companies

NetApp logo
NTAPUS — Revenue
$902M+10.1%
Our Bond, Inc. logo
OBAIUS — Revenue
$2.34M+4.5%
Ambarella logo
AMBAUS — Revenue
$1.92M+25.4%
FuelCell Energy logo
FCELUS — Revenue
$14.09M-40.0%
HTF
HTFLUS — Revenue
$48.99M+42.8%
Harmonic logo
HLITUS — Revenue
$97.22M+56.3%

Other financials

Income statement

See full
Revenue$311.4M-1.5%
Gross profit$208.3M-2.9%
Operating income$75.5M+95.0%
Net income$51.0M+126%
EPS (diluted)$0.32+129%

Balance sheet

See full
Cash & equivalents$209.8M+49.2%
Total debt$290.3M-31.4%
Total equity$2.1B+3.3%
Total assets$2.6B-3.5%

Cash flow

See full
Operating cash flow$86.7M+111%
CapEx$9.1M-10.2%
Free cash flow$77.6M+150%

Valuation

See full
Market cap$11.22B+43.5%
Enterprise value$11.3B+39.5%
P/E74.9×+16.9×
P/S9.3×+2.9×

Profitability

See full
Gross margin65%-0.8pp
Operating margin14.2%-7.9pp
Net margin10.9%-6.7pp
FCF margin22.3%+4.0pp

Returns & leverage

See full
Return on equity6.5%-3.9pp
Debt / equity0.1×-0.1×
Current ratio4.5×+0.8×

Where this comes from

Reported directly by Bio-Techne in its filing.

Tagged under the XBRL concept us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.

The source filing: Bio-Techne’s 10-Q, filed May 6, 2026.

Filed
May 6, 2026, 4:31 PM EDT
Fiscal quarter
Q3 FY2026
Calendar quarter
Q1 2026
Accession
0001104659-26-056302
Line itemQuarter Ended / March 31, 2026Quarter Ended / March 31, 2025Nine Months Ended / March 31, 2026Nine Months Ended / March 31, 2025
United States$167,479$181,921$469,276$506,842
EMEA, excluding United Kingdom73,44666,501213,928195,956
United Kingdom14,89112,85241,82440,039
APAC, excluding Greater China21,82021,24563,70958,377
Greater China26,01224,48377,14973,557
Rest of World7,7679,17927,96127,900
Net sales$311,415$316,181$893,847$902,671

Item 1. Condensed Consolidated Financial Statements (Unaudited)

FAQ

What is Bio-Techne's US — revenue?
Bio-Techne (TECH) reported US — revenue of $167.48M in Q1 2026.
How has Bio-Techne's US — revenue changed year-over-year?
Bio-Techne's US — revenue decreased by 7.9% year-over-year, from $181.92M to $167.48M.
What is the long-term trend for Bio-Techne's US — revenue?
Over 3 years (2022 to 2025), Bio-Techne's US — revenue has grown at a 3.6% compound annual growth rate (CAGR), from $614.11M to $683.23M.
What does US — revenue mean?
This metric represents the total net sales generated from contracts with customers within the United States, excluding any sales-related taxes collected on behalf of government authorities. It serves as the primary indicator of the company's commercial performance and market penetration within the domestic geographic region. By stripping out tax components, it provides a clean view of the underlying demand for the company's products and services.

Ask your AI about Bio-Techne's us — revenue.

Connect your AI assistant and compare segments, right in your chat.

Connect your AI
Harbor at dusk
Claude